MiMedx Group, Inc. announced that it has received FDA clearance to market the Paradís Vaso Shield device. The device is designed for use as a cover for vessels following anterior vertebral surgery. The proprietary, patented, and biocompatible polyvinyl alcohol polymer (PVA) membrane may reduce the risk of associated injury following anterior vertebral surgeries by providing a vessel cover. The Paradís Vaso Shield was intended to help physicians protect vessels following anterior vertebral surgery. Dr. Rebeccah Brown, COO of SpineMedica, a MiMedx Group subsidiary, said, "Anterior spine surgery involves risk of injury to patients due to complications associated with vessel management. It is our belief that this product is ideally suited to address this issue in patients undergoing surgery in this complex area of the body." Parker H. "Pete" Petit, Chairman, President and CEO, commented, "This is MiMedx Group's first product to receive FDA clearance. In my opinion, the Company has a complement of exciting new technologies, and a number of our products will proceed to the clearance and approval process in 2009. We will keep our shareholders fully informed on our progress." The company’s Paradís Vaso Shield is to be used by inserting it between specific anatomy, such as the anterior spine and adjacent aorta or iliac arteries (vessels). The product may be trimmed and fitted easily at the time of use and is sutured into place. The Paradís Vaso Shield is a permanent and biocompatible implant which is suitable as a cover for vessels. The proprietary and patented manufacturing process produces a product that is pliable, constructed in a single-layer and hydrophilic.